Viking Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.17%)
Viking Therapeutics | 8-K: Current report
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ZANTE GREG
Viking Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rouan Sarah Kathryn
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SINGLETON J MATTHEW
Viking Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viking Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viking Therapeutics | 10-Q: Q3 2024 Earnings Report
Viking Therapeutics | 8-K: Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Viking Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION :(4.2%)
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SINGLETON J MATTHEW
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lian Brian
Viking Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viking Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lian Brian
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SINGLETON J MATTHEW
Viking Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viking Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Viking Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lian Brian
No Data
No Data